Dexcel Pharma

Dexcel Pharma, an international pharmaceutical company, specializes in developing, manufacturing, and marketing innovative prescription, generics, and over-the-counter pharmaceutical products. Established in 1968, Dexcel Pharma has grown to become Israel’s largest private pharmaceutical company, with a diverse product portfolio of over 85 branded and generic products in more than 175 dosage forms. These products are distributed in key markets such as the US, the UK, and Germany, as well as in over 30 countries worldwide through subsidiaries and a trusted network of partners. Dexcel Pharma operates in the Health Care, Manufacturing, and Pharmaceutical industries. Although specific details of the last investment and investors are not available, the company's strong presence and extensive product range indicate its potential for continued growth and success. With a longstanding history and global reach, Dexcel Pharma presents an attractive opportunity for venture capital firms with an interest in the pharmaceutical sector. The company's commitment to innovation, diverse product offerings, and international footprint position it as an appealing investment prospect for those looking to enter or expand in the pharmaceutical market.